D M Savarese - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

D M Savarese

Showing results (11-20 of 12) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 12 results.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2001

Phase II study of docetaxel, estramustine, and low-dose hydrocortisone in men with hormone-refractory prostate cancer: a final report of CALGB 9780. Cancer and Leukemia Group BD M Savarese, S Halabi, V Hars, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1993

Phase I study of high-dose piroxantrone with granulocyte colony-stimulating factorD M Savarese, A M Denicoff, S L Berg, et al.

Pageof 2

Search research articles

Showing results (11-20 of 12) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 12 results.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2001

Phase II study of docetaxel, estramustine, and low-dose hydrocortisone in men with hormone-refractory prostate cancer: a final report of CALGB 9780. Cancer and Leukemia Group BD M Savarese, S Halabi, V Hars, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1993

Phase I study of high-dose piroxantrone with granulocyte colony-stimulating factorD M Savarese, A M Denicoff, S L Berg, et al.

Pageof 2